Literature DB >> 10706904

Ehlers-Danlos syndrome.

R E Pyeritz.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10706904     DOI： 10.1056/NEJM200003093421009

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Ehlers-Danlos syndrome.

Authors:  Rajin Choudhury; Valeriu Revenco; Radu Darciuc
Journal:  BMJ Case Rep       Date:  2009-07-14

2.  [Ehlers-Danlos syndrome and bilateral, dystrophic breast calcifications].

Authors:  M Meier-Meitinger; B Adamietz; R Schulz-Wendtland
Journal:  Radiologe       Date:  2009-09       Impact factor: 0.635

3.  Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.

Authors:  Sherene Shalhub; James H Black; Alana C Cecchi; Zhi Xu; Ben F Griswold; Hazim J Safi; Dianna M Milewicz; Nazli B McDonnell
Journal:  J Vasc Surg       Date:  2014-03-18       Impact factor: 4.268

4.  A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Kristofer Charlton-Ouw; Devin Zarkowsky; Dawn M Coleman; Frank M Davis; Ellen S Regalado; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-21       Impact factor: 4.268

5.  Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.

Authors:  Gerd A Müller; Uwe Hansen; Zhi Xu; Benjamin Griswold; Mark I Talan; Nazli B McDonnell; Wilfried Briest
Journal:  FASEB J       Date:  2011-10-28       Impact factor: 5.191

6.  Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events.

Authors:  John W Petersen; J Yellowlees Douglas
Journal:  Med Hypotheses       Date:  2013-07-03       Impact factor: 1.538

7.  Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome.

Authors:  Wilfried Briest; Timothy K Cooper; Hyun-Jin Tae; Melissa Krawczyk; Nazli B McDonnell; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

8.  Ehlers-Danlos syndrome associated with cleft lip and palate.

Authors:  Pearlie Ww Tan; Colin Song; Donald Lalonde
Journal:  Can J Plast Surg       Date:  2009

9.  Mechanisms of cerebellar tonsil herniation in patients with Chiari malformations as guide to clinical management.

Authors:  Thomas H Milhorat; Misao Nishikawa; Roger W Kula; Yosef D Dlugacz
Journal:  Acta Neurochir (Wien)       Date:  2010-05-04       Impact factor: 2.216

10.  N-(2-Aminoethyl) Ethanolamine-Induced Morphological, Biochemical, and Biophysical Alterations in Vascular Matrix Associated With Dissecting Aortic Aneurysm.

Authors:  Zhenping Chen; Ya Xu; Paul Bujalowski; Andres F Oberhauser; Paul J Boor
Journal:  Toxicol Sci       Date:  2015-10-05       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.